Preliminary Clinical Experience with the First Dual Chamber Pacemaker Defibrillator
Preliminary Clinical Experience with the First Dual Chamber Pacemaker Defibrillator
复制标题
第一台双腔起搏器除颤器的初步临床经验
DOI：
--
复制
发表时间：
1997
期刊：
影响因子：
--
通讯作者：
F. Murgatroyd
中科院分区：
文献类型：
--
作者：
T. Lavergne;J. Daubert;M. Chauvin;E. Dolla;S. Kacet;A. Leenhardt;P. Mabo;P. Ritter;N. Sadoul;N. Saoudi;C. Henry;R. Nitzsché;A. Ripart;F. Murgatroyd
VT检测缺乏特异性是当前ICD的显著缺点。在一项法国多中心研究中，18名患者植入了Defender 9001（ELA Medical），这是一种使用双腔起搏和心律失常检测的ICD。在7.1 ± 4.5个月的平均随访期内，分析了器械存储器中记录的176次心动过速发作，并将医生诊断与器械诊断进行了比较。所有122例VT/VF发作均被正确诊断，53例室上性快速性心律失常中有51例被正确诊断。两次房颤发作伴快速规则心室率被视为室性心动过速，第三次发作被视为室性心动过速，无法明确诊断。除了双腔起搏的血流动力学益处之外，双腔起搏器除颤器还提供了改进的诊断特异性而不损失灵敏度。(PACE 1997年;20个
The lack of specificity of VT detection is a significant shortcoming of current ICDs. In a French multicenter study, 18 patients underwent implantation of the Defender 9001 (ELA Medical), an ICD utilizing dual chamber pacing and arrhythmia detection. Over a mean follow‐up period of 7.1 ± 4.5 months, 176 tachycardia episodes recorded in the device memory were analyzed, and physician diagnosis was compared with that by the device. All 122 VT/VF episodes were correctly diagnosed, as were 51 of 53 supraventricular tachyarrhythmias. Two episodes of AF with rapid regular ventricular rates were treated as VT, and a third episode, treated as VT, could not be diagnosed with certainty. A dual chamber pacemaker defibrillator offers improved diagnostic specificity without loss of sensitivity, in addition to the hemodynamic benefit of dual chamber pacing. (PACE 1997;20